Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rcpeng.2022.02.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The British Geriatrics Society's position on assisted dying.
Age Ageing
January 2025
Medicine Clinical Board, University Hospital of Wales Cardiff, Cardiff, UK.
In response to increased focus on the issue of Assisted Dying (AD) in the UK due to the presentation of The Terminally Ill Adults (End of Life) Bill 2024-25 [1] and bills before parliaments in the Isle of Man, Guernsey and Scotland, the British Geriatric Society (BGS) recently developed a position statement opposing legalisation of AD in the UK [2]. We set out our key reasoning behind this position, namely the current adverse health and social care context and significant concern about whether effective safeguards can be created to protect older people with complex needs from undue harms. The BGS asks for improved, personalised, multidisciplinary care for older people at the end of their lives, including high-quality palliative and end-of-life care.
View Article and Find Full Text PDFIndividual application patterns of Cannabis-based Medicines in Germany - Descriptive evaluation of a patient survey and discussion from a forensic perspective.
Forensic Sci Int
December 2024
Department of Forensic Toxicology, Institute of Legal Medicine, University Medical Center, Am Pulverturm 3, Mainz D-55131, Germany. Electronic address:
Background: An increasing number of countries have legalised cannabis for medicinal purposes in recent years leading to tensions with other regulatory frameworks. Some countries grant a medical defence according to their drug driving legislations. This may lead to specific medico-legal assessments relating to the participation of cannabis patients in road traffic.
View Article and Find Full Text PDFBackground: Cannabis is increasingly used and debates about the legalisation of the recreational use of cannabis are ongoing. In this prospective, placebo-controlled study in healthy volunteers not regularly consuming cannabis, subjective psychotropic and somatic effects after a single dose of intravenous THC were assessed and quantified over 48 h.
Methods: Twenty-five healthy volunteers received a single IV bolus of THC and 6 received normal saline.
Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review.
Biomed Pharmacother
January 2025
Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health & Life Sciences, University of Liverpool, Liverpool L69 3GE, UK; Center of Excellence in Preventive and Integrative Medicine, Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; Bumrungrad International Hospital, Bangkok 10110, Thailand.
With legalisation of cannabis for both medicinal and recreational use expanding to more world nations, grasping its effects on the human body is vital. The microbiome is critical to human health and disease, and accumulating data suggests that it is influenced by a variety of external variables, including marijuana/cannabis and cannabinoids. We therefore conducted a comprehensive assessment of the literature to analyse cannabis and cannabinoid effects on the human microbiota.
View Article and Find Full Text PDFHarm reduction for perinatal cannabis use: protocol for a scoping review of clinical practices.
BMJ Open
December 2024
Department of Psychiatry and Human Behavior, Brown University, Warren Alpert Medical School, Providence, Rhode Island, USA.
Introduction: The American College of Obstetricians and Gynaecologists recommends against cannabis use during pregnancy and lactation ('perinatal cannabis use') given its association with negative parent-child health outcomes. However, cannabis is becoming increasingly available and used during pregnancy, and perceptions of safety are correspondingly increasing. For individuals who are unable or unwilling to cease use during pregnancy and lactation, harm reduction is the best available evidence-based practice to promote health.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!